Health-related quality-of-life effects of watchful waiting re-evaluated in SPCG-4

Nature Clinical Practice Urology

Volumn 6, Issue 3, 2009, Pages 124-125

  McDermott, David W ^a   Sanda, Martin G ^b,c  

^a Harvard Longwood Program   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL TRIAL; DEPRESSION; ERECTILE DYSFUNCTION; HUMAN; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; TREATMENT OUTCOME; URINE INCONTINENCE; WATCHFUL WAITING; WELLBEING;

EID: 62549140082     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro1314     Document Type: Note

References (7)

1. Bill-Axelson A et al. (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352: 1977-1984
2. Steineck G et al. (2002) Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347: 790-796
3. Johansson E et al. (2008) Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: The randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial. Eur Urol [doi:10.1016/j.eururo.2008.08.054]
4. Arredondo SA et al. (2004) Watchful waiting and health related quality of life for patients with localized prostate cancer: Data from CaPSURE. J Urol 172: 1830-1834
5. Dall'Era MA et al. (2008) Active surveillance for early-stage prostate cancer: Review of the current literature. Cancer 112 1650-1659
6. Potosky AL et al. (2002) Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst 94: 430-437
7. Sanda MG et al. (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358: 1250-1261